Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis
Background & Aims: In unselected patients with cirrhosis, those with reductions in hepatic venous pressure gradient (HVPG) to below a defined threshold (responders) have a reduced risk of variceal hemorrhage (VH) and death. We performed a meta-analysis to compare this effect in patients with vs...
| Autores: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/148219 |
| Acceso en línea: | https://hdl.handle.net/2445/148219 |
| Access Level: | acceso abierto |
| Palabra clave: | Cirrosi hepàtica Hipertensió portal Hepatic cirrhosis Portal hypertension |
| id |
ES_ca5eaf4fbef94298029acee7fc277fc2 |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/148219 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisTurco, LauraVillanueva, CàndidMura, Vincenzo LaGarcía Pagán, Juan CarlosReiberger, ThomasGenescà, JoanGroszmann, Roberto J.Sharma, Barjesh C.Merkel, CarloBureau, ChristopheAlvarado Tapias, EdilmarGonzález-Abraldes Iglesias, JuanAlbillos, AgustínBañares, RafaelPeck-Radosavljevic, MarkusAugustin, SalvadorSarin, Shiv K.Bosch, JaimeGarcía-Tsao, GuadalupeCirrosi hepàticaHipertensió portalHepatic cirrhosisPortal hypertensionBackground & Aims: In unselected patients with cirrhosis, those with reductions in hepatic venous pressure gradient (HVPG) to below a defined threshold (responders) have a reduced risk of variceal hemorrhage (VH) and death. We performed a meta-analysis to compare this effect in patients with vs without ascites. Methods: We collected data from 15 studies of primary or secondary prophylaxis of VH that reported data on VH and death in responders vs nonresponders. We included studies in which data on ascites at baseline and on other relevant outcomes during follow-up evaluation were available. We performed separate meta-analyses for patients with vs without ascites. Results: Of the 1113 patients included in the studies, 968 patients (87%) had been treated with nonselective β-blockers. In 993 patients (89%), HVPG response was defined as a decrease of more than 20% from baseline (>10% in 11% of patients) or to less than 12 mm Hg. In the 661 patients without ascites, responders (n = 329; 50%) had significantly lower odds of events (ascites, VH, or encephalopathy) than nonresponders (odds ratio [OR], 0.35; 95% CI, 0.22–0.56). Odds of death or liver transplantation were also significantly lower among responders than nonresponders (OR, 0.50, 95% CI, 0.32–0.78). In the 452 patients with ascites, responders (n = 188; 42%) had significantly lower odds of events (VH, refractory ascites, spontaneous bacterial peritonitis, or hepatorenal syndrome) than nonresponders (OR, 0.27; 95% CI, 0.16–0.43). Overall, odds of death or liver transplantation were lower among responders (OR, 0.47; 95% CI, 0.29–0.75). No heterogeneity was observed among studies. Conclusions: In a meta-analysis of clinical trials, we found that patients with cirrhosis with and without ascites who respond to treatment with nonselective β-blockers (based on reductions in HVPG) have a reduced risk of events, death, or liver transplantation.Elsevier2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/148219Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1016/j.cgh.2019.05.050Clinical Gastroenterology and Hepatology, 2020, vol. 18, num. 2, p. 313-327.e6https://doi.org/10.1016/j.cgh.2019.05.050(c) AGA Institute, 2020info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1482192026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| title |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| spellingShingle |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis Turco, Laura Cirrosi hepàtica Hipertensió portal Hepatic cirrhosis Portal hypertension |
| title_short |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| title_full |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| title_fullStr |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| title_full_unstemmed |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| title_sort |
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis |
| dc.creator.none.fl_str_mv |
Turco, Laura Villanueva, Càndid Mura, Vincenzo La García Pagán, Juan Carlos Reiberger, Thomas Genescà, Joan Groszmann, Roberto J. Sharma, Barjesh C. Merkel, Carlo Bureau, Christophe Alvarado Tapias, Edilmar González-Abraldes Iglesias, Juan Albillos, Agustín Bañares, Rafael Peck-Radosavljevic, Markus Augustin, Salvador Sarin, Shiv K. Bosch, Jaime García-Tsao, Guadalupe |
| author |
Turco, Laura |
| author_facet |
Turco, Laura Villanueva, Càndid Mura, Vincenzo La García Pagán, Juan Carlos Reiberger, Thomas Genescà, Joan Groszmann, Roberto J. Sharma, Barjesh C. Merkel, Carlo Bureau, Christophe Alvarado Tapias, Edilmar González-Abraldes Iglesias, Juan Albillos, Agustín Bañares, Rafael Peck-Radosavljevic, Markus Augustin, Salvador Sarin, Shiv K. Bosch, Jaime García-Tsao, Guadalupe |
| author_role |
author |
| author2 |
Villanueva, Càndid Mura, Vincenzo La García Pagán, Juan Carlos Reiberger, Thomas Genescà, Joan Groszmann, Roberto J. Sharma, Barjesh C. Merkel, Carlo Bureau, Christophe Alvarado Tapias, Edilmar González-Abraldes Iglesias, Juan Albillos, Agustín Bañares, Rafael Peck-Radosavljevic, Markus Augustin, Salvador Sarin, Shiv K. Bosch, Jaime García-Tsao, Guadalupe |
| author2_role |
author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Cirrosi hepàtica Hipertensió portal Hepatic cirrhosis Portal hypertension |
| topic |
Cirrosi hepàtica Hipertensió portal Hepatic cirrhosis Portal hypertension |
| description |
Background & Aims: In unselected patients with cirrhosis, those with reductions in hepatic venous pressure gradient (HVPG) to below a defined threshold (responders) have a reduced risk of variceal hemorrhage (VH) and death. We performed a meta-analysis to compare this effect in patients with vs without ascites. Methods: We collected data from 15 studies of primary or secondary prophylaxis of VH that reported data on VH and death in responders vs nonresponders. We included studies in which data on ascites at baseline and on other relevant outcomes during follow-up evaluation were available. We performed separate meta-analyses for patients with vs without ascites. Results: Of the 1113 patients included in the studies, 968 patients (87%) had been treated with nonselective β-blockers. In 993 patients (89%), HVPG response was defined as a decrease of more than 20% from baseline (>10% in 11% of patients) or to less than 12 mm Hg. In the 661 patients without ascites, responders (n = 329; 50%) had significantly lower odds of events (ascites, VH, or encephalopathy) than nonresponders (odds ratio [OR], 0.35; 95% CI, 0.22–0.56). Odds of death or liver transplantation were also significantly lower among responders than nonresponders (OR, 0.50, 95% CI, 0.32–0.78). In the 452 patients with ascites, responders (n = 188; 42%) had significantly lower odds of events (VH, refractory ascites, spontaneous bacterial peritonitis, or hepatorenal syndrome) than nonresponders (OR, 0.27; 95% CI, 0.16–0.43). Overall, odds of death or liver transplantation were lower among responders (OR, 0.47; 95% CI, 0.29–0.75). No heterogeneity was observed among studies. Conclusions: In a meta-analysis of clinical trials, we found that patients with cirrhosis with and without ascites who respond to treatment with nonselective β-blockers (based on reductions in HVPG) have a reduced risk of events, death, or liver transplantation. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion |
| format |
article |
| status_str |
acceptedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/148219 |
| url |
https://hdl.handle.net/2445/148219 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Versió postprint del document publicat a: https://doi.org/10.1016/j.cgh.2019.05.050 Clinical Gastroenterology and Hepatology, 2020, vol. 18, num. 2, p. 313-327.e6 https://doi.org/10.1016/j.cgh.2019.05.050 |
| dc.rights.none.fl_str_mv |
(c) AGA Institute, 2020 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
(c) AGA Institute, 2020 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419473901977600 |
| score |
15,300719 |